tradingkey.logo

Bone Biologics Corp

BBLGW
Ver gráfico detallado

10.010USD

0.000
Cierre 09/19, 16:00ETCotizaciones retrasadas 15 min
0.00Cap. mercado
--P/E TTM
Intraday
1m
30m
1h
D
W
M
D

Hoy

0.00%

5 Días

+20.60%

1 Mes

+Infinity%

6 Meses

-35.83%

Año hasta la fecha

-74.97%

Un año

+Infinity%

Ver gráfico detallado

Puntuación de acciones TradingKey

Sin datos de puntuación

Noticias

Próximamente más noticias, permanezca atento...

Indicadores financieros

BPA

Sin datos

Ingresos totales

Sin datos

Compañía

Bone Biologics Corporation is a developer of orthobiologic products for spine fusion markets. It is focusing development efforts for its bone graft substitute product on bone regeneration in spinal fusion procedures, while additionally having rights to trauma and osteoporosis applications. It is a medical device company that is focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with demineralized bone matrix (DBM), is an osteopromotive recombinant protein that provides target specific control over bone regeneration. Its platform technology is its NELL-1, a proprietary skeletal specific growth factor which is a bone void filler. NELL-1 provides regulation over skeletal tissue formation and stem cell differentiation during bone regeneration. The DBM Demineralized Bone Putty provided as part of the convenience kit with NELL-1/DBM is a Class II device. DBM Putty is a matrix composed of processed human cortical bone.
Símbolo de cotizaciónBBLGW
CompañíaBone Biologics Corp
Director ejecutivoMr. Jeffrey Frelick
Sitio Webhttps://www.bonebiologics.com/
KeyAI